ArticleRheumatology international2025
Anti-citrullinated protein antibodies may be prognostic factor for vascularization of the synovial membrane in patients with high activity of RA.
Article in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This single-center study aimed to evaluate relationship between the concentration of anti-citrullinated protein antibodies (ACPA) and the degree of synovial perfusion in patients with high disease activity of rheumatoid arthritis (RA). The study enrolled 60 patients diagnosed with RA and group of 20 patients with psoriasis arthritis (PsA). Different laboratory variables were assessed and particularly ACPA (U/ML), disease activity was calculated by DAS 28(ESR) and simplified disease activity score (SDAI). The degree of the synovial membrane vascularization was assessed using power doppler US (PDUS) and additionally vascularity index was measured by PDUS index (INDEX%) in the ROI (region of interest). Correlation between the concentration of ACPA and INDEX% in RA group was confirmed as week positivity indicating that ACPA may be a prognostic factor for vascularization of the synovial membrane in patients with RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.